These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11310590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
    Liu ZD, Khodr HH, Lu SL, Hider RC.
    J Pharm Pharmacol; 2000 Mar; 52(3):263-72. PubMed ID: 10757413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S, Link G, Grady RW, Hider RC, Peter HH, Hershko C.
    Blood; 1992 Jan 01; 79(1):248-53. PubMed ID: 1728313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators.
    Moridani MY, Tilbrook GS, Khodr HH, Hider RC.
    J Pharm Pharmacol; 2002 Mar 01; 54(3):349-64. PubMed ID: 11902801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake.
    Ma Y, Roy S, Kong X, Chen Y, Liu D, Hider RC.
    J Med Chem; 2012 Mar 08; 55(5):2185-95. PubMed ID: 22339047
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators.
    Liu ZD, Liu DY, Lu SL, Hider RC.
    Arzneimittelforschung; 2000 May 08; 50(5):461-70. PubMed ID: 10858874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydrolytic and metabolic characteristics of the esters of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41), potentially useful iron chelators.
    Liu DY, Liu ZD, Lu SL, Hider RC.
    Pharmacol Toxicol; 2000 May 08; 86(5):228-33. PubMed ID: 10862505
    [Abstract] [Full Text] [Related]

  • 14. In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin-loaded rat model.
    Liu ZD, Lu SL, Hider RC.
    Biochem Pharmacol; 1999 Mar 01; 57(5):559-66. PubMed ID: 9952320
    [Abstract] [Full Text] [Related]

  • 15. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
    Dehkordi LS, Liu ZD, Hider RC.
    Eur J Med Chem; 2008 May 01; 43(5):1035-47. PubMed ID: 17869385
    [Abstract] [Full Text] [Related]

  • 16. Dose response studies using desferrioxamine and orally active chelators in a mouse model.
    Kontoghiorghes GJ.
    Scand J Haematol; 1986 Jul 01; 37(1):63-70. PubMed ID: 3764334
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential.
    Liu ZD, Liu DY, Lu SL, Hider RC.
    J Pharm Pharmacol; 1999 May 01; 51(5):555-64. PubMed ID: 10411215
    [Abstract] [Full Text] [Related]

  • 18. Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity.
    Streater M, Taylor PD, Hider RC, Porter J.
    J Med Chem; 1990 Jun 01; 33(6):1749-55. PubMed ID: 2342069
    [Abstract] [Full Text] [Related]

  • 19. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
    Zanninelli G, Choudury R, Loréal O, Guyader D, Lescoat G, Arnaud J, Verna R, Cosson B, Singh S, Hider RC, Brissot P.
    J Hepatol; 1997 Jul 01; 27(1):176-84. PubMed ID: 9252093
    [Abstract] [Full Text] [Related]

  • 20. Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice.
    Porter JB, Morgan J, Hoyes KP, Burke LC, Huehns ER, Hider RC.
    Blood; 1990 Dec 01; 76(11):2389-96. PubMed ID: 2257308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.